The Pharmaceutical Society of Australia is undergoing an “operational transformation” amid rumours of staff layoffs
A number of anonymous pharmacy sector sources have hinted at staff redundancies at the PSA, with up to 15 positions suggested to be lost.
A spokesperson for the organisation would not confirm or deny whether this was the case, but said that the PSA is “restructuring the way we do things to make sure we deliver the best possible service for members”.
PSA national president Dr Chris Freeman provided a statement to the AJP, saying that “Dr Shane Jackson will remain as PSA’s CEO through to at least the end of 2019, to drive the 7th Community Pharmacy Agreement negotiations, and guide the operational transformation that will build a stronger Society”.
“PSA’s operational transformation is focussed on delivering value for our members across advocacy, policy, education and training within the PSA,” Dr Freeman said.
“The transformation includes significant investment in our digital offering and member experience.”
The spokesperson said the PSA would not comment further on the matter.
The move follows a number of changes at the PSA, including the resignation as CEO by Graham Catt in February 2019.
Mr Catt had served less than one year in the position, following the resignation in November 2017 of his predecessor Lance Emerson.
After Mr Catt’s resignation, Dr Jackson was then appointed as interim CEO, with Belinda Wood as Deputy CEO.
Ms Wood was appointed General Manager in April 2018.
Dr Jackson had been president of the Society since July 2017, but stepped down from the position in December 2018 to focus on his family, though he remained on the PSA Board as vice president and chair of its policy and advocacy committee, as well as taking on the interim CEO role once Mr Catt left.
PSA also opened its new Canberra headquarters, Pharmacy House, in March 2018.